AKT1 and cancer: Somatic activating mutations in the PI3K/AKT/mTOR pathway are among the most common mutations identified in cancer and have been shown to cause a spectrum of overgrowth syndromes including PIK3CA-Related Overgrowth Spectrum, Proteus syndrome, and brain overgrowth conditions (6).